Concepedia
Statistics
Publications
5
Citations
261
H-Index
Active since
2003
Affiliations
Novartis (Switzerland)(Current)
University of Pisa
Novartis Institutes for BioMedical Research
The University of Melbourne
Edi Schuepbach is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and receptor pharmacology.
Publications per year
2003–2013
The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
Géraldine M. Mang, Thomas Dürst, Hugo Bürki et al. · SLEEP · 2012 · 100 citations · Full text
Life Sciences, Neuroscience, Pharmacology +16
β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors
Caroline Nunn, Magnus Rueping, Daniel Langenegger et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2003 · 51 citations
Medicine, Medicinal Chemistry, Pharmacology +11
Pharmacological characterisation of native somatostatin receptors in AtT‐20 mouse tumour corticotrophs
Davide Cervia, Caroline Nunn, Dominique Fehlmann et al. · British Journal of Pharmacology · 2003 · 45 citations · Full text
Medicine, Endocrinology, Pharmacology +14
Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors
Gabrielle E. Callander, Morenike Olorunda, Dominique Monna et al. · Frontiers in Neuroscience · 2013 · 41 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +13
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors
Davide Cervia, Daniel Langenegger, Edi Schuepbach et al. · Neuropharmacology · 2005 · 24 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +9
1–5 of 5